Reporting Quality Assessment of Randomized Controlled Trials Published in Hepatitis Monthly

摘要

It is important that randomized clinical trials (RCTs),as the most valuable research method for assessing the efficacyof treatments, are reported with the highest possiblelevel of quality (1). To evaluate the quality of publishedRCTs reported in Hepatitis monthly, we examined whetherthere was a change in the quality of reporting over time.Of the 610 articles published from 2010 to 2014, 583 nontrialor non-human trials were screened, and 27 trials wereidentified. Within these 27 trials, ten reports were withouta control group and failed to meet our eligibility criteria.Therefore, 17 RCTs were identified. We completed a comprehensivequality assessment of each report using theshort form of the CONSORT 2010 checklist (www.consortstatement.org)and a five-point quality assessment instrumentcalled the Jadad scale (2).